BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26117406)

  • 1. Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy.
    Iglay K; Cao X; Mavros P; Joshi K; Yu S; Tunceli K
    Clin Ther; 2015 Aug; 37(8):1813-21.e1. PubMed ID: 26117406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Adv Ther; 2012 Aug; 29(8):675-90. PubMed ID: 22898791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.
    Han S; Iglay K; Davies MJ; Zhang Q; Radican L
    Curr Med Res Opin; 2012 Jun; 28(6):969-77. PubMed ID: 22494018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
    Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
    Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA; Amonkar MM; Hebborn A; Altman R
    Curr Med Res Opin; 2005 Sep; 21(9):1453-60. PubMed ID: 16197664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism.
    Laliberté F; Bookhart BK; Nelson WW; Lefebvre P; Schein JR; Rondeau-Leclaire J; Duh MS
    Patient; 2013; 6(3):213-24. PubMed ID: 23857628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing frequency and medication adherence in chronic disease.
    Coleman CI; Limone B; Sobieraj DM; Lee S; Roberts MS; Kaur R; Alam T
    J Manag Care Pharm; 2012 Sep; 18(7):527-39. PubMed ID: 22971206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and dosing frequency of common medications for cardiovascular patients.
    Bae JP; Dobesh PP; Klepser DG; Anderson JD; Zagar AJ; McCollam PL; Tomlin ME
    Am J Manag Care; 2012 Mar; 18(3):139-46. PubMed ID: 22435907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis.
    Caldeira D; Vaz-Carneiro A; Costa J
    Rev Port Cardiol; 2014; 33(7-8):431-7. PubMed ID: 25070671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis.
    Kothawala P; Badamgarav E; Ryu S; Miller RM; Halbert RJ
    Mayo Clin Proc; 2007 Dec; 82(12):1493-501. PubMed ID: 18053457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group.
    Hiligsmann M; Salas M; Hughes DA; Manias E; Gwadry-Sridhar FH; Linck P; Cowell W
    Osteoporos Int; 2013 Dec; 24(12):2907-18. PubMed ID: 23636230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women.
    Recker RR; Gallagher R; MacCosbe PE
    Mayo Clin Proc; 2005 Jul; 80(7):856-61. PubMed ID: 16007889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review.
    Fatoye F; Smith P; Gebrye T; Yeowell G
    BMJ Open; 2019 Apr; 9(4):e027049. PubMed ID: 30987990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation.
    Yu M; Xie J; Fernandez Lando L; Kabul S; Swindle RW
    Clin Ther; 2016 Jan; 38(1):149-60. PubMed ID: 26706658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis.
    Weeda ER; Coleman CI; McHorney CA; Crivera C; Schein JR; Sobieraj DM
    Int J Cardiol; 2016 Aug; 216():104-9. PubMed ID: 27144286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men.
    Mikyas Y; Agodoa I; Yurgin N
    Appl Health Econ Health Policy; 2014 Jun; 12(3):267-77. PubMed ID: 24477429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Daily, Weekly, and Monthly Dosing Regimens of Bisphosphonates for Osteoporosis Treatment in Postmenopausal Women in Japan: A Retrospective Study Using Claims Data.
    Kosaka Y; Sugiyama T; Hara K; Kobayashi Y
    Tohoku J Exp Med; 2021 Oct; 255(2):147-155. PubMed ID: 34690222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of persistence and compliance with bisphosphonates for osteoporosis.
    Cramer JA; Gold DT; Silverman SL; Lewiecki EM
    Osteoporos Int; 2007 Aug; 18(8):1023-31. PubMed ID: 17308956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and Outcomes Associated With Adherence to Weekly Alendronate in US Military Veterans: Clinical Research Study.
    Bou Malham S; Bowe B; Sen SK; Zhang RM; Sterkel B; Dunn JP
    J Prim Care Community Health; 2019; 10():2150132719884300. PubMed ID: 31779523
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.